Vor Biopharma
VOR
VOR
49 hedge funds and large institutions have $151M invested in Vor Biopharma in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
31% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 16
44% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 18
Holders
49
Holding in Top 10
3
Calls
$12K
Puts
–
Top Buyers
| 1 | +$5.66M | |
| 2 | +$2.04M | |
| 3 | +$1.35M | |
| 4 |
E
Ergoteles
New York
|
+$350K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$345K |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$1.2M | |
| 3 | -$743K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$622K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$500K |